IR NEWS
-
09/06/2021
Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2022(IFRS)
（401KB）
-
08/10/2021
FY2022/3 Q1, Supplementary Material(Apr.1 to Jun.30 2021)
（1,207KB）
-
06/17/2021
License & Supply Agreement with Laboratorio Elea Phenix S.A. on Infliximab Biosimilar in Argentine market
（509KB）
-
06/14/2021
Consolidated Financial Results for the Fiscal Year Ended March 31, 2021 (IFRS)
（263KB）
-
05/29/2021
Notice of the 57th Ordinary General Meeting of Shareholders
（191KB）
